Select Academic Publications
Peer-Reviewed Articles 2023-2021
Patel VR, Tsai AK, Blaes A, Parikh RB, Adamson AS, Gupta A. Association Between Price and Appropriateness of Cancer-Related Medical Information Generated by Chat-Based Artificial Intelligence Models. JCO Clin Cancer Inform. 2023 Jun;7:e2300041. doi: 10.1200/CCI.23.00041.
Patel VR, Roberson ML, Pignone MP, Adamson AS. Risk of Mortality After a Diagnosis of Melanoma In Situ. JAMA Dermatol. 2023 Jul 1;159(7):703-710. doi: 10.1001/jamadermatol.2023.1494.
Cobb CBC, Heath CR, Byrd AS, McKinley-Grant LJ, Callender V, Adamson AS, Brown S 3rd, Desai SR, Glass DA 2nd, Jaleel T, Okoye GA, Taylor SC, Harvey VM. The Skin of Color Society's Meeting the Challenge Summit, 2022: Diversity in Dermatology Clinical Trials Proceedings. JAMA Dermatol. 2023 Jul 1;159(7):757-762. doi: 10.1001/jamadermatol.2023.1285.
Wongvibulsin S, Adamson AS. Deep learning for Mpox: Advances, challenges, and opportunities. Med. 2023 May 12;4(5):283-284. doi: 10.1016/j.medj.2023.04.002.
Patel VR, Hussaini SMQ, Blaes AH, Morgans AK, Haynes AB, Adamson AS, Gupta A. Trends in the Prevalence of Functional Limitations Among US Cancer Survivors, 1999-2018. JAMA Oncol. 2023 Jul 1;9(7):1001-1003. doi: 10.1001/jamaoncol.2023.1180.
Adamson AS. The USPSTF I Statement on Skin Cancer Screening-Not a Disappointment but an Opportunity. JAMA Dermatol. 2023 Jun 1;159(6):579-581. doi: 10.1001/jamadermatol.2023.0706.
Adamson AS, Welch H, Welch HG. Melanoma Incidence by Sex, Indoor Tanning, and Body Site-Reply. JAMA Intern Med. 2023 Apr 1;183(4):390-391. doi: 10.1001/jamainternmed.2022.6734.
Bailey K, Adamson AS. Health care disparities and dermatology: A duty to delve deeper. J Am Acad Dermatol. 2023 Feb;88(2):e107-e108. doi: 10.1016/j.jaad.2022.10.059. Epub 2022 Nov 11.
Adamson AS, Welch H, Welch HG. Association of UV Radiation Exposure, Diagnostic Scrutiny, and Melanoma Incidence in US Counties. JAMA Intern Med. 2022 Oct 3;182(11):1181-9. doi: 10.1001/jamainternmed.2022.4342.
Roberson ML, Adamson AS, Shinkai K; JAMA Dermatology Editorial Board. JAMA Dermatology's Commitment to Diversity, Equity, and Inclusion. JAMA Dermatol. 2022 Oct 1;158(10):1125-1126. doi: 10.1001/jamadermatol.2022.3970.
Adamson AS, Suarez EA, Welch HG. Melanoma Overdiagnosis Is Not the Key Problem-Reply. JAMA Dermatol. 2022 Sep 1;158(9):1083-1084. doi: 10.1001/jamadermatol.2022.2926.
Patel K, Cervantes JA, Keeling B, Adamson AS. A Fixed Drug Eruption to Medroxyprogesterone Acetate Injectable Suspension. Cutis. 2022 Mar;109(3):E12-E14. doi: 10.12788/cutis.0489
Clarke EL, Willenbrink TJ, Shelton M, Naeem A, Custer J, Lundgren AD, Boothe WD, Rathouz PJ, Adamson AS, Fox MC, Jambusaria-Pahlajani A. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer. JAMA Dermatol. 2022 Aug 1;158(8):919-922. doi: 10.1001/jamadermatol.2022.1802.
Adamson AS, Abraham I. Decision Curve Analysis and the Net Benefit of Novel Tests. JAMA Dermatol. 2022 Jun 1;158(6):684. doi: 10.1001/jamadermatol.2022.0976.
Marchetti MA, Adamson AS, Halpern AC. Differentiating Between Lead-Time Bias and True Survival Benefits When Discussing Racial and Ethnic Disparities in Melanoma-Reply. JAMA Dermatol. 2022 Jun 1;158(6):701-702. doi: 10.1001/jamadermatol.2022.0331.
Chen HW, Vuong VA, Adamson AS, Nguyen KD. Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017. JAMA Dermatol. 2022 May 1;158(5):581-583. doi: 10.1001/jamadermatol.2022.0073.
Kolitz E, Lopes FCPS, Arffa M, Pineider J, Bogucka R, Adamson AS. UV Exposure and the Risk of Keratinocyte Carcinoma in Skin of Color: A Systematic Review. JAMA Dermatol. 2022 May 1;158(5):542-546. doi: 10.1001/jamadermatol.2022.0263.
Kurtansky NR, Manci RN, Bello DM, Adamson AS, Shoushtari AN, Wehner MR, Ariyan CE, Marghoob AA, Marchetti MA, Rotemberg V. Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. Br J Dermatol. 2022 Sep;187(3):430-432. doi: 10.1111/bjd.21251.
Adamson AS, Suarez EA, Welch HG. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US. JAMA Dermatol. 2022 Apr 1;158(4):426-431. doi: 10.1001/jamadermatol.2022.0139.
Angra D, Roehrs PA, Googe PB, Adamson AS. Pediatric-Onset Refractory Lupus Erythematosus Panniculitis Treated With Rituximab. Cutis. 2021 Aug;108(2):E44-E46. doi: 10.12788/cutis.0351.
Croce EA, Levy ML, Adamson AS, Matsui EC. Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations. J Allergy Clin Immunol. 2021 Nov;148(5):1104-1111. doi: 10.1016/j.jaci.2021.09.015.
Marchetti MA, Adamson AS, Halpern AC. Melanoma and Racial Health Disparities in Black Individuals-Facts, Fallacies, and Fixes. JAMA Dermatol. 2021 Sep 1;157(9):1031-1032. doi: 10.1001/jamadermatol.2021.2215.
Adamson AS, Mazer BL, Welch HG. The Rapid Rise in Cutaneous Melanoma Diagnoses. Reply. N Engl J Med. 2021 Apr 8;384(14):e54. doi: 10.1056/NEJMc2101980.
Diao JA, Adamson AS. Representation and misdiagnosis of dark skin in a large-scale visual diagnostic challenge. J Am Acad Dermatol. 2022 Apr;86(4):950-951. doi: 10.1016/j.jaad.2021.03.088.
Zhang Y, Ali K, George JA, Reichenberg JS, Fox MC, Adamson AS, Tunnell JW, Markey MK. Toward automated assessment of mole similarity on dermoscopic images. J Med Imaging (Bellingham). 2021 Jan;8(1):014506.
Petitt CE, Kiracofe E, Adamson A, Barbieri JS. Prior authorizations in dermatology and impact on patient care: An updated survey of US dermatology providers and staff by the American Academy of Dermatology. Dermatol Online J. 2021 Jan 15;27(1):13030/qt990631n9.
Welch HG, Mazer BL, Adamson AS. The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021 Jan 7;384(1):72-79.
Nguyen KD, Chen HW, Adamson AS. Changes in Use of Radiotherapy Among Dermatologists From 2013 to 2017. JAMA Dermatol. 2021 Mar 1;157(3):322-325.
Lopes FCPS, Sleiman MG, Sebastian K, Bogucka R, Jacobs EA, Adamson AS. UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review. JAMA Dermatol. 2021 Feb 1;157(2):213-219.
Adamson AS, Lipoff JB. Reconsidering Named Honorifics in Medicine-the Troubling Legacy of Dermatologist Albert Kligman. JAMA Dermatol. 2021 Feb 1;157(2):153-155.
Peer-Reviewed Articles 2020
Matsui EC, Perry TT, Adamson AS. An Antiracist Framework for Racial and Ethnic Health Disparities Research. Pediatrics. 2020 Dec;146(6):e2020018572.
Barbieri JS, Tan JKL, Adamson AS. Active Comparator Trial Designs Used to Promote Development of Innovative New Medications. Cutis. 2020 Sep;106(3):E4-E6.
Adamson AS, Jackson BE, Baggett CD, Thomas NE, Pignone MP. Association of surgical interval and survival among hospital and non-hospital based patients with melanoma in North Carolina. Arch Dermatol Res. 2020 Oct 23:1-9.
Pignone MP, Adamson AS. Keratinocyte Carcinomas: Should We Screen for Them? Am Fam Physician. 2020 Sep 15;102(6):330-331.
Mostaghimi A, Adamson A, Barbieri J. Evaluation of the Merits and Limitations of Evidence-Based Medicine-Reply. JAMA Dermatol. 2020 Aug 1;156(8):925-926.
Feng H, Shih AF, Feng PW, Stein JA, Adamson AS. Concordance between dermatologist self-reported and industry-reported interactions at a national dermatology conference. Cutis. 2020 Apr;105(4):203-208;E1.
Kovarik CL, Chu EY, Adamson AS. Gene Expression Profile Testing for Thin Melanoma: Evidence to Support Clinical Use Remains Thin. JAMA Dermatol. 2020 Apr 15.
Daneshjou R, Adamson AS. Twitter Journal Clubs: Medical Education in the Era of Social Media. JAMA Dermatol. 2020 Mar 18.
Adamson AS, Shinkai K. Systemic Absorption of Sunscreen: Balancing Benefits With Unknown Harms. JAMA. 2020 Jan 21;323(3):223-224.
Adamson AS, Jarmul JA, Pignone MP. Screening for Melanoma in Men: a Cost-Effectiveness Analysis. J Gen Intern Med. 2020 Apr;35(4):1175-1181. Epub 2019 Nov 8.
Peer-Reviewed Articles 2019
Adamson AS, Welch HG. Machine Learning and the Cancer-Diagnosis Problem - No Gold Standard. N Engl J Med. 2019 Dec 12;381(24):2285-2287.
Pournamdari AB, Tkachenko E, Barbieri J, Adamson AS, Mostaghimi A. A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review. JAMA Dermatol. 2019 Oct 23.
Adamson AS, Pignone MP. Eliminating Copayments for Skin Cancer Screening: A Public Health Policy With Insufficient Evidence. JAMA Dermatol. 2019 Aug 16.
Shelton ME, Adamson AS. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer. Dermatol Clin. 2019 Oct;37(4):425-433. Epub 2019 Jul 10.
Kovarik C, Lee I, Ko J; Ad Hoc Task Force on Augmented Intelligence, additional members include: Adamson A, Otley C, Kvedar J, Vedak P, Huang S, Fitzgerald M, Chaudhari R. Commentary: Position Statement on Augmented Intelligence (AuI). J Am Acad Dermatol. 2019 Oct;81(4):998-1000. Epub 2019 Jun 25.
Matsui EC, Adamson AS, Peng RD. Time’s Up to Adopt a Biopsychosocial Model to Address Racial and Ethnic Disparities in Asthma. J Allergy Clin Immunol. 2019 Jun;143(6):2024-2025. Epub 2019 Mar 30.
Wu S, Adamson AS. Cutaneous toxicity associated with enfortumab vedontin treatment of metastatic urothelial carcinoma. Dermatol Online J. 2019 Feb 15;25(2)
Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries. J Gen Intern Med. 2019 Feb;34(2):176-178.
Albrecht J, Adamson AS, Barbieri J, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM;AADA Task Force on Drug Pricing and Transparency. Lack of an FDA indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 Feb;80(2):577-578. Epub 2018 Sep 20.
Peer-Reviewed Articles 2018
Zeitany A, Adamson AS. Treatment of non-melanoma skin cancer in the elderly. Current Geriatrics Reports 7 (4), 216-221.
Adamson AS, Nelson KC. Observation of Moderately Dysplastic Nevi With Positive Margins: Are We There Yet? . JAMA Dermatol. 2018 Dec 1;154(12):1387-1388.
Mostaghimi A, Adamson AS. Translating Administrative Health Care Data to Treatment Decisions in Dermatology: The Blind Men and the Elephant. JAMA Dermatol. 2018 Nov 1;154(11):1256-1257.
Adamson AS, Smith A. Machine Learning and Health Care Disparities in Dermatology. JAMA Dermatology. 2018 Nov 1;154(11):1247-1248.
Selected Media Coverage:
AI-Driven Dermatology Could Leave Dark-Skinned Patients Behind by Angela Lashbrook The Atlantic, August 16th, 2018
Vuong KT, Walker J, Powell H, Thomas NE, Jonas DE, Adamson AS. Surgical re-excision versus observation for histologically dysplastic nevi: A systematic review of associated clinical outcomes. Br J Dermatol. 2018 Sep;179(3):590-598. Epub 2018 Jun 21.
Accompanying COMMENTARY:
Greenwald E, Stein JA. Highlighting the need for prospective randomized studies on the management of dysplastic naevi. Br J Dermatol. 2018 Sep;179(3):554-555.
Rutherford A, Glass DA, Suarez EA, Adamson AS. Prescription-level factors associated with primary nonadherence to dermatologic medications. J Dermatolog Treat. 2018 May;29(3):300-304. Epub 2017 Aug 18.
Powell HB, Adamson AS. Medicare Part D payments for brand and generic drugs prescribed by Dermatologists. J Am Acad Dermatol. 2018 Feb 22.
Moo-Young JA, Suarez EA, Adamson AS. Distance to pharmacy and risk of medication primary nonadherence. Dermatol Online J. 2018 Feb 15;24(2).
Song H, Adamson AS, Mostaghimi A. Trends in Medicare Spending on Topical Immunomodulators and Chemotherapies. J Am Acad Dermatol. 2018 Jan;78(1):173-175.
Adamson AS, Suarez EA, McDaniel P, Leiphart PA, Zeitany A, Kirby JS. Geographic Distribution of Nonphysician Clinicians Who Independently Billed Medicare for Common Dermatologic Services in 2014. JAMA Dermatol. 2018 Jan 1;154(1):30-36.
Peer-Reviewed Articles 2017
Adamson AS, Zhou L, Baggett CD, Thomas NE, Meyer AM. Association of Delays in Surgery for Melanoma With Insurance Type. JAMA Dermatol. 2017 Nov 1;153(11).
Accompanying Editorial:
Lott JP. Delay and Disparity in Time to Surgical Treatment for Melanoma. JAMA Dermatol. 2017 Nov 1;153(11):1094-1095.
Accompanying Author Interview:
Association of Delays in Surgery for Melanoma With Insurance Type. JAMA Dermatol. Interview with Adewole S. Adamson, MD, MPP, October 4th, 2017.
Adamson AS, Dusetzina SB. Mohs Micrographic Surgery Use in the United States Based on Medicare Data-Reply. JAMA Dermatol. 2017 Aug 1;153(8):835.
Song H, Adamson A, Mostaghimi A. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings. JAMA Dermatol. 2017 Aug 1;153(8):755-759.
Accompanying Editorial:
Kirby JS, Miller JJ. Generic Drugs-Changes in Cost and Challenges in Practice. JAMA Dermatol. 2017 Aug 1;153(8):745-746.
Adamson AS. Should we refer to skin as "ethnic?". J Am Acad Dermatol. Jun;76(6):1224-1225.
Adamson AS, Glass DA 2nd, Suarez EA. Patient-provider race and sex concordance and the risk for medication primary nonadherence. J Am Acad Dermatol. 2017 Jun;76(6):1193-1195.
Adamson AS. The Economics Burden of Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:79-92.
Adamson AS, Wright SW, Pandya AG. A Missed Opportunity to Discuss Racial and Gender Bias in Dermatology. JAMA Dermatol. 2017 Jan 1:153(1):110-111.
Adamson AS, Dusetzina SB. Characteristics of Medicare payments to dermatologists in 2013. JAMA Dermatol. 2017 Jan 1;153(1):95-97.
Adamson AS, Suarez EA Gorman AR. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population. JAMA Dermatol. 2017 Jan 1;153(1):49-54.
Accompanying Author Interview:
Method of Prescribing and Primary Nonadherence to Dermatologic Medication. JAMA Dermatol. Interview with Adewole S. Adamson, MD, MPP, October 26th, 2016; http://jamanetwork.com/learning/audio-player/13654976
Peer-Reviewed Articles 2016 - Previous
Liu PW, Green WL, Adamson AS. Perineal Rash and Perianal Pain. J Emerg Med. 2015 Aug;49(2):e59-60.
Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A. Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene. PLoS One. 2013;8(3):e59367.
O'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS, Fan S. Signal transduction and Th17 cell differentiation. Microbes Infect. 2009 Apr;11(5):599-611.
Adamson AS, Collins K, Laurence A, O'Shea JJ. The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol. 2009 Apr;21(2):161-6.
Shet AS, Hoffmann TJ, Jirouskova M, Janczak CA, Stevens JR, Adamson A, Mohandas N, Manci EA, Cynober T, Coller BS. Morphological and functional platelet abnormalities in Berkeley sickle cell mice. Blood Cells Mol Dis. 2008 Jul-Aug;41(1):109-18.
Book Chapters
Adamson AS (2017): The Economic Impact of Atopic Dermatitis, in Management of Atopic Dermatitis: Methods and Challenges; Fortson E, Feldman S, Strowd L, eds. Advances in Experimental Medicine and Biology. 1st edition. Page 79-92. ISBN-10: 3319648039.
Other Scholarship
Waters H, Adamson A. The Health and Economic Implications of the Use of Tanning Devices in the U.S. J Cancer Policy. February 2017.
Selected Media Coverage:
Reuters, March 2, 2017:
Tanning beds tied to U.S. health costs of $343 million a year by Lisa Rapaport.
STAT News, February 28, 2017:
Skin cancer from tanning beds costs US $343 million per year by Megan Thielking
Adewole Adamson, Ghideon Ezaz. Mississippi State Employee Wellness Programs: Opportunities and Keys to Success in Combating Obesity. Master’s Thesis. John F. Kennedy School of Government, 2011.
Adamson, Adewole. TIMP1 Regulation in CD4+ Effector T Cells. Honors Thesis. Harvard Medical School, 2011.
John J. O’Shea, Arian Laurence, Adewole S. Adamson. CD4+ T-Cell diversity. Nature Reviews Immunology. Vol 9 No 2, February 2009.